Bio-Path Holdings, Inc. Reports First Quarter 2013 Operational and Financial Results
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Bio-Path Holdings, Inc., (OTCQX: BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced operational and financial results for the first quarter ended March 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
Bio-Path Holdings, Inc., (OTCQX: BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced operational and financial results for the first quarter ended March 31, 2013.
Help employers find you! Check out all the jobs and post your resume.